UK 1745

Drug Profile

UK 1745

Latest Information Update: 26 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Unknown
  • Developer Kowa; Nonindustrial source
  • Class Antiarrhythmics; Cardiotonics; Indoles; Vasodilators
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias; Heart failure

Most Recent Events

  • 01 May 1998 A study has been added to the Heart Failure pharmacodynamics section
  • 22 Sep 1997 A study has been added to the Arrhythmias pharmacodynamics section
  • 13 Dec 1996 Preclinical development for Arrhythmias in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top